Methylenedioxymethylphentermine

Methylenedioxymethylphentermine (MDMP) is a psychoactive drug and research chemical of the phenethylamine and amphetamine chemical classes. It acts as a serotonin-norepinephrine-dopamine releasing agent (SNDRA) and is known for its entactogenic effects.

History

MDMP was first synthesized in the 1960s by a team of chemists at the pharmaceutical company Merck KGaA. It was initially developed as a potential antidepressant medication, but its use was discontinued due to concerns about its potential for abuse and addiction.

Pharmacology

MDMP acts primarily as a serotonin releasing agent, with secondary effects on norepinephrine and dopamine release. It is structurally similar to other phenethylamine derivatives such as MDMA and MDEA, and shares many of their effects.

Effects

The effects of MDMP can vary widely depending on the dose, the individual's physiology, and the context in which it is used. Common effects include feelings of euphoria, increased sociability, and heightened sensory perception. However, it can also cause a range of negative effects, including anxiety, paranoia, and potentially dangerous increases in heart rate and blood pressure.

Legal status

MDMP is currently a controlled substance in many countries, including the United States, where it is classified as a Schedule I drug under the Controlled Substances Act.

See also

• Phenethylamine
• Amphetamine
• MDMA
• MDEA
• Controlled Substances Act